Serco, GB0033055624

Serco outlines UK outsourcing role, shares in focus after government stance

Published on 06/23/2026 at 22:10 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

Serco faces a shifting UK outsourcing landscape after ministers spoke of an “age of outsourcing over”, while the FTSE 250 group continues to secure long-term public service contracts. Investors watch how the stock navigates policy changes and contract renewals.

Serco, GB0033055624, Illustration mit AI erstellt.
Serco, GB0033055624, Illustration mit AI erstellt.

By Christina Vogel, Background & Management desk. Reviewed prior to publication on 2026-06-23, 20:07.

Serco Group plc (GB0033055624) sits at the center of the UK outsourcing debate as policymakers reassess the state’s reliance on private contractors. In mid-June UK ministers described an “age of outsourcing over” while outlining plans to bring more public services back in-house, according to recent coverage of Westminster discussions on public service delivery.

What recent UK comments signal

Serco is one of the best-known UK government services providers alongside peers such as Capita and G4S, with major contracts in justice, immigration, health and transport that are primarily anchored in the UK public sector market. MarketScreener company profile on Serco In June, UK ministers publicly argued that the “age of outsourcing” for core services is “over”, a phrase widely cited in political reporting of their policy shift toward greater state control of critical functions.

Those remarks come after several years in which Serco and other FTSE 250 contractors have relied heavily on long-term UK government frameworks, meaning any structural change in procurement models can influence growth visibility and margin profiles.

Serco’s long-running public contracts

Despite a more cautious tone from ministers, Serco continues to win and extend multi-year agreements, underlining the state’s ongoing dependence on private capacity in several areas. A May 2026 report on the Norfolk hospital deal In late May Serco agreed a 10-year extension of its facilities management contract at Norfolk and Norwich University Hospital in England, adding a decade of revenue visibility in health support services.

That Norfolk hospital extension follows a broader pipeline of justice, immigration, defense and transport contracts, illustrating how deeply embedded the company remains in UK and international public service delivery even as the political narrative around outsourcing becomes more skeptical.

Go deeper

All news and analysis on the Serco shares

Track Serco’s contract pipeline, political headlines and price data in one place with the dedicated topic overview.

How Serco earns its money

Serco generates most of its revenue by operating and managing public services on behalf of governments, including running prisons and immigration centers, delivering non-clinical services in hospitals, managing transport operations and supporting defense and space programs in the UK, Europe, the Middle East, Asia-Pacific and North America.

Where the stock trades today

The Serco shares (GB0033055624) last traded on the London Stock Exchange at around 2.70 euros equivalent per share on 2026-06-22, based on MarketScreener data, with the stock quoted in pence on its primary LSE line and translated for secondary euro reporting.

Key data on the Serco shares

  • Company: Serco Group plc
  • ISIN: GB0033055624
  • WKN: 870737
  • Ticker: SRP
  • Trading venue: London Stock Exchange
  • Price (as of 2026-06-22, 21:44): 2.70 EUR (LSE quote translated)
  • Market cap: 2.70 billion EUR (as of 2026-06-22)
  • Sector / industry: Support Services / Government Services Outsourcing
  • Index membership: FTSE 250
  • Next earnings date: not officially scheduled

More on the Serco shares in social media

This article is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any securities. All data are based on publicly available sources believed to be reliable but cannot be guaranteed.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | GB0033055624 | SERCO | boerse | 69613702 | bgmi